Burundi vs Ghana: Cause of death, by non-communicable diseases, ages 15-59, male
Burundi
44.3%
in 2021
Ghana
42.5%
in 2021
Burundi rank
117th
Ghana rank
120th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Burundi
- Ghana
How they compare
Burundi currently reports 44.3% against 42.5% in Ghana, a difference of 1.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Ghana ahead.
Burundi ranks 117th and Ghana ranks 120th of 185 countries.
Across the 3 decades both report, Burundi averaged higher in 1 and Ghana in 2.
Head to head by decade
| Decade | Burundi | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 36.8% | 22.8% | Ghana |
| 2010s | 37.9% | 41.9% | 4.0% | Ghana |
| 2020s | 43.4% | 42.7% | 0.7% | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Burundi or Ghana?
- Burundi, at 44.3% against 42.5% in Ghana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Burundi and Ghana?
- 1.8%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Ghana?
- 6 years are reported by both, from 2000 to 2021.
- How do Burundi and Ghana rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Burundi ranks 117th and Ghana ranks 120th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.